28077790 |
FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors
Levis, M,
Nguyen, B,
Williams, AB,
Small, D,
Brown, P,
Li, L,
Young, DJ,
Ma, H
|
Oncotarget |
2017 |
22504184 |
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Perl, AE,
Chin, CS,
Schadt, EE,
Shah, NP,
Smith, CC,
Kuriyan, J,
Hunt, JP,
Wang, Q,
Salerno, S,
Wang, S,
Levis, MJ,
Kasarskis, A,
Zarrinkar, PP,
Travers, KJ,
Damon, LE
|
Nature |
2012 |
23430109 |
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD
Salerno, S,
Zhu, X,
Stewart, WK,
Lasater, EA,
Damon, LE,
Shah, NP,
Smith, CC,
Lin, KC
|
Blood |
2013 |